Main Menu
Menu

Blog

Publish Date
Blog
Why C4IP Supports the PREVAIL Act

The PREVAIL Act provides a comprehensive set of reforms that — after a decade’s worth of experience with the Patent Trial and...

Blog
‘Tis the Season — of Counterfeits?

Counterfeiting is a multi-billion-dollar enterprise that puts consumers at serious risk. Poorly-made laptop batteries can overheat. Knock-off cosmetics may contain toxic chemicals....

Blog
This Month in IP: October 2025

Strong, consistent IP protections throughout U.S. history enabled the creation of innovative and useful technologies that we use regularly today. From firefighting...

Blog
C4IP Coalition Updates: October 2025

October Highlights: C4IP Advocates for the Patent Eligibility Restoration Act On October 8, the Senate Judiciary Subcommittee on Intellectual Property held a...

Blog
Why Continued Innovation Matters: Keytruda and the “Product Hopping” Myth

The FDA recently approved a new version of Keytruda, a cancer immunotherapy medicine that is one of the world’s most successful drugs....

BlogFact Checks
Fact Check: The Myth of So-Called “Royalty Free” and “Open” Standards

The word “open” has become increasingly misused in the world of technology standards. In policy and antitrust terms, an open standard is...

Blog
Highlights from the October 8 PERA Hearing

On October 8, the Senate Judiciary Subcommittee on Intellectual Property held a hearing on the Patent Eligibility Restoration Act (PERA) to examine...

Blog
Inventor Spotlight: Malcom McLean

C4IP is honoring Malcom McLean (1913-2001), whose invention of containerized shipping revolutionized global trade. Born into a farming family in North Carolina,...

Blog
This Month in IP: September 2025

Strong, consistent IP protections throughout U.S. history enabled the creation of innovative and useful technologies that we use regularly today. From fabric...

Blog
C4IP Coalition Updates: September 2025

September Highlights: C4IP Launches New Website to Correct Patent Misinformation For years, the Initiative for Medicines, Access & Knowledge — better known...

Blog
Inventor Spotlight: John B. Goodenough

This month, C4IP is honoring John B. Goodenough (1922-2023), whose work on the invention of the lithium-ion battery powers billions of high-tech...

Blog
Why C4IP Supports the Patent Eligibility Restoration Act of 2025 (PERA)

This chaotic area of law harms American innovation and competitiveness Without Congressional consideration or endorsement, the Supreme Court has fundamentally altered the...

Blog:

Blog:

Why C4IP Supports the PREVAIL Act,

07/05/2023
Blog:

Blog:

‘Tis the Season — of Counterfeits?,

11/14/2025
Blog:

Blog:

This Month in IP: October 2025,

11/10/2025
Blog:

Blog:

C4IP Coalition Updates: October 2025,

11/10/2025
Blog:

Blog:

Why Continued Innovation Matters: Keytruda and the “Product Hopping” Myth,

11/03/2025
Blog:

Blog, Fact Checks:

Fact Check: The Myth of So-Called “Royalty Free” and “Open” Standards,

10/30/2025
Blog:

Blog:

Highlights from the October 8 PERA Hearing,

10/24/2025
Blog:

Blog:

Inventor Spotlight: Malcom McLean,

10/17/2025
Blog:

Blog:

This Month in IP: September 2025,

10/10/2025
Blog:

Blog:

C4IP Coalition Updates: September 2025,

10/10/2025
Blog:

Blog:

Inventor Spotlight: John B. Goodenough,

09/26/2025
Blog:

Blog:

Why C4IP Supports the Patent Eligibility Restoration Act of 2025 (PERA),

09/25/2025
Scroll to Top